Biological Markers - Analysis
Research News and Information

Sunday, November 22, 2009

Radiation response of cancer stem-like cells from established human cell lines after sorting for surface markers.

13 Nov 2009 PURPOSE: A subpopulation of cancer stem-like cells (CSLC) is hypothesized to exist in different cancer cell lines and to mediate radioresistance in solid tumors. METHODS AND MATERIALS: Cells were stained for CSLC markers and sorted ... Read more...

How a US regulator can encourage new science.

30 Oct 2009 The Center for Drug Evaluation and Research at the US Food and Drug Administration (FDA) is developing a process to qualify biomarkers for use under particular conditions. As part of this effort, Goodsaid et al. have carried out work, described in ... Read more...

Diclofenac sodium inhibits NFkappaB transcription in osteoclasts.

30 Oct 2009 A non-steroidal anti-inflammatory drug, diclofenac, acts efficiently against inflammation; however, down-regulation of diclofenac on bone remodeling has raised concerns. The inhibitory mechanisms of diclofenac are poorly understood. We hypothesized ... Read more...

Latest indexed articles for 'Biological Markers - Analysis'

These are the very latest articles for this heading:

• Radiation response of cancer stem-like cells from established human cell lines after sorting for surface markers. 13 Nov 2009
• How a US regulator can encourage new science. 30 Oct 2009
• Diclofenac sodium inhibits NFkappaB transcription in osteoclasts. 30 Oct 2009
• CCR5 down-regulates osteoclast function in orthodontic tooth movement. 30 Oct 2009
• The influence of thyroid hormones on periodontitis-related bone loss and tooth-supporting alveolar bone: a histological study in rats. 20 Oct 2009
• Rapid resurgence of marine productivity after the Cretaceous-Paleogene mass extinction. 30 Sep 2009
• The care of patients with an abdominal aortic aneurysm: the Society for Vascular Surgery practice guidelines. 29 Sep 2009
• Markers for the validation of reported dietary intake in adults with cystic fibrosis. 29 Sep 2009
• Validating dietary intake with biochemical markers. 29 Sep 2009
• Biomarkers of oxidative stress in heart failure. 29 Sep 2009
• [Locally advanced head and neck cancers: recommendations of an expert panel and perspectives for the use of TPF regimen (docetaxel, cisplatin and fluoro-uracil) as induction therapy] 29 Sep 2009
• Direct reprogramming of human neural stem cells by OCT4. 29 Sep 2009
• Mycobacterial antigen-induced T helper type 1 (Th1) and Th2 reactivity of peripheral blood mononuclear cells from diabetic and non-diabetic tuberculosis patients and Mycobacterium bovis bacilli Calmette-Guérin (BCG)-vaccinated healthy subjects. 29 Sep 2009
• Apoptosis in patients with acute myocarditis. 29 Sep 2009
• Analysis of microRNA expression profiles during the cell cycle in synchronized HeLa cells. 28 Sep 2009
• Prediction of birth weight by cotinine levels during pregnancy in a population of black smokers. 26 Sep 2009
• [Integration of a new risk marker into cardiovascular prevention, using coronary calcium as an example] 21 Sep 2009
• [Role of biomarkers for risk stratification in the prevention of cardiovascular diseases] 21 Sep 2009
• Baseline CSF p-tau levels independently predict progression of hippocampal atrophy in Alzheimer disease. 20 Sep 2009
• The occupant as a source of house dust bacteria. 17 Sep 2009

See a longer list of these articles.

Technical information about 'Biological Markers'

Definition: Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, environmental exposure and its effects, disease diagnosis, metabolic processes, substance abuse, pregnancy, cell line development, epidemiologic studies, etc.

Registry Number: 0

Descriptor UI: D015415

Alternative terms: Biological Markers; Markers, Biological; Biomarkers; Marker, Biological; Biological Marker; Biologic Marker; Marker, Biologic; Biologic Markers; Markers, Biologic; Viral Markers; Viral Marker; Marker, Viral; Markers, Viral; Biochemical Marker; Marker, Biochemical; Markers, Biochemical; Biochemical Markers; Surrogate Endpoints; Endpoints, Surrogate; Surrogate End Points; End Points, Surrogate; Surrogate Endpoint; Endpoint, Surrogate; Surrogate End Point; End Point, Surrogate; Markers, Immunologic; Marker, Immunologic; Immunologic Marker; Immunologic Markers; Immune Marker; Marker, Immune; Immune Markers; Markers, Immune; Markers, Laboratory; Laboratory Markers; Marker, Laboratory; Laboratory Marker; Serum Markers; Markers, Serum; Serum Marker; Marker, Serum; Surrogate Markers; Markers, Surrogate; Surrogate Marker; Marker, Surrogate; Markers, Clinical; Clinical Markers; Marker, Clinical; Clinical Marker;

Related Mesh Headings: Molecular Probes;

Allowable Qualifiers: analysis; blood; cerebrospinal fluid; chemistry; metabolism; urine;

Tree Number: D23.101;

History Note: 89

Technical Notes: IM general only; coordinate NIM with specific substance (IM); note that many specific markers are available; DF: BIOL MARKERS